Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers.
A. Singhi, B. George, J. Greenbowe, Jon H. Chung, J. Suh, A. Maitra, S. Klempner, A. Hendifar, J. Milind, T. Golan, R. Brand, A. Zureikat, Somak Roy, A. Schrock, V. Miller, J. Ross, Siraj M. Ali, N. Bahary
Gastroenterology